The effect of gemini (16‐s‐16, s = 4, 5, 6) surfactants on the reaction rate of ninhydrin with [Cu(II)‐Gly‐Tyr]+ complex was determined using a spectrophotometric technique. The ninhydrin concentration was kept in excess in order to maintain pseudo‐first‐order conditions. The reaction followed irreversible first‐ and fractional‐order kinetics with respect to [Cu(II)‐Gly‐Tyr]+ and [ninhydrin], respectively. It is found that gemini surfactants effectively catalyze the reaction. The rate constants (kψ) first increase and then become relatively constant with increasing gemini surfactant concentration similar to conventional cetyltrimethylammonium bromide. At higher gemini surfactant concentration a third region of increasing kψ is observed. The unusual third region is ascribed to changes in micellar morphology. The kinetic data has been analyzed using a micellar pseudo‐phase model.
The present work concerns with the effect of alkanediyl-α,ω-bis(dimethylcetylammonium bromide) gemini surfactants on the reaction rate of ninhydrin with glycyl-glycine. The spectra showed peaks at 400 nm and 570 nm in aqueous and aqueous–micellar media indicating the formation of the same product. Under pseudo-first-order conditions of excess ninhydrin, the reaction followed an irreversible first- and fractional-order kinetics with respect to [Gly-Gly] and [ninhydrin]. Also, the rate constants (kψ) increases and leveling-off regions are found with [geminis] (akin to conventional cetyltrimethylammonium bromide, CTAB), a third-region of increasing kψ is observed at higher [geminis]. The kinetic data in gemini micellar medium have been examined with the pseudo-phase model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.